Amplatzer Amulet LAAO vs. NOAC
CATALYST
Clinical Trial of Atrial Fibrillation Patients Comparing Left Atrial Appendage Occlusion Therapy to Non-vitamin K Antagonist Oral Anticoagulants
1 other identifier
interventional
2,650
16 countries
127
Brief Summary
The objective of this trial is to evaluate the safety and effectiveness of the Amulet LAA occluder compared to NOAC therapy in patients with non-valvular AF at increased risk for ischemic stroke and who are recommended for long-term NOAC therapy. The clinical investigation is a prospective, randomized, multicenter active control worldwide trial. Subjects will be randomized in a 1:1 ratio between the Amulet LAA occlusion device ("Device Group") and a commercially available NOAC medication ("Control Group"). The choice of NOAC in the Control Group will be left to study physician discretion.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable atrial-fibrillation
Started Jul 2020
Longer than P75 for not_applicable atrial-fibrillation
127 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 9, 2020
CompletedFirst Posted
Study publicly available on registry
January 13, 2020
CompletedStudy Start
First participant enrolled
July 7, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2029
ExpectedStudy Completion
Last participant's last visit for all outcomes
April 1, 2031
February 10, 2026
February 1, 2026
8.5 years
January 9, 2020
February 6, 2026
Conditions
Outcome Measures
Primary Outcomes (3)
Composite of ischemic stroke, systemic embolism, or cardiovascular (CV) mortality
non-inferiority
2 years
Major bleeding or clinically relevant non-major bleeding (CRNMB) events, excluding procedure related events
superiority
2 years
Composite of ischemic stroke or systemic embolism
non-inferiority
3 years
Secondary Outcomes (3)
Major bleeding or CRNMB events
2 years
Major bleeding or CRNMB events
2 years
Disabling or fatal strokes
2 years
Study Arms (2)
Device Group
EXPERIMENTALRandomized to Amplatzer Amulet LAA occluder
Control Group
ACTIVE COMPARATORRandomized to NOAC
Interventions
Initiation or continuation of a NOAC drug
Implantation of an Amplatzer Amulet left atrial appendage occluder
Eligibility Criteria
You may qualify if:
- Documented paroxysmal, persistent, or permanent non-valvular AF (documentation must include an electrocardiogram, Holter, or event recorder)
- At high risk of stroke or systemic embolism, defined as a CHA2DS2-VASc score of ≥ 2 for men and ≥ 3 for women
- Eligible for long-term NOAC therapy
- Able to comply with the required NOAC medication regimen if randomized to the Control Group
- Able to comply with the required medication regimen post-device implant if subject is randomized to the Device Group or subject is a Roll-in
- Able to understand, and is willing to provide, written informed consent to participate in the trial, prior to any clinical investigation related procedure or assessment
- years of age or older, or the age of legal consent
- Able and willing to return for required follow-up visits and assessments
You may not qualify if:
- Requires long-term OAC therapy for a condition other than AF
- Planned cardiac intervention or surgery, which is invasive or requires sedation or anesthesia, within 3 months following randomization, other than study-related procedures such as LAAO and cardiac imaging (if applicable)
- Known contraindication to, or allergic to, aspirin, clopidogrel, or OAC medication use
- Indicated for P2Y12 platelet inhibitor for \>1 year post-randomization
- In the opinion of the investigator, is considered at high risk for general anesthesia and general anesthesia is planned for the study procedure
- Has undergone atrial septal defect (ASD) repair or has an ASD closure device present
- Has undergone patent foramen ovale (PFO) repair or has a PFO closure device implanted
- Is implanted with a mechanical valve prosthesis
- Is implanted with an inferior vena cava filter
- History of rheumatic or congenital mitral valve heart disease
- Has any of the customary contraindications for a percutaneous catheterization procedure (e.g. subject is too small to accommodate the ICE probe (if planned) or required catheters, or subject has active infection or bleeding disorder)
- Customary contraindications for TEE/TOE (e.g., presence of esophageal varices, esophageal stricture, or history of esophageal cancer)
- Experienced stroke or transient ischemic attack (TIA) within 90 days prior to randomization or implant procedure (as applicable)
- Underwent any cardiac or non-cardiac intervention or surgery within 30 days prior to randomization
- Underwent catheter ablation for AF or atrial flutter within 60 days prior to randomization
- +17 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (127)
University Hospital - Univ. of Alabama at Birmingham (UAB)
Birmingham, Alabama, 35249, United States
Heart Center Research, LLC
Huntsville, Alabama, 35801, United States
Arizona Cardiovascular Research Center
Phoenix, Arizona, 85016, United States
Tucson Medical Center
Tucson, Arizona, 85712, United States
Arrhythmia Research Group
Jonesboro, Arkansas, 72401, United States
UAMS Medical Center
Little Rock, Arkansas, 72205, United States
Scripps Health
La Jolla, California, 92037, United States
Kaiser Permanente Los Angeles Medical Center
Los Angeles, California, 90027, United States
Huntington Memorial Hospital
Pasadena, California, 91109, United States
Mercy Medical Group - Cardiology
Sacramento, California, 95819, United States
South Denver Cardiology Associates PC
Littleton, Colorado, 80120, United States
MedStar Washington Hospital Center
Washington D.C., District of Columbia, 20010, United States
AdventHealth Florida Cardiology - Altamonte Springs
Altamonte Springs, Florida, 32701, United States
St. Vincent's Medical Center
Jacksonville, Florida, 32204, United States
Baptist Medical Center
Jacksonville, Florida, 32207, United States
AdventHealth Florida Cardiology - Lake Mary
Lake Mary, Florida, 32746, United States
NCH Healthcare System
Naples, Florida, 34102, United States
AdventHealth Orlando
Orlando, Florida, 32803, United States
AdventHealth Florida Cardiology - Oviedo
Oviedo, Florida, 32765, United States
Sarasota Memorial Hospital
Sarasota, Florida, 34239, United States
Piedmont Heart Institute
Atlanta, Georgia, 30309, United States
Emory University Hospital
Atlanta, Georgia, 30322, United States
Northside Hospital
Atlanta, Georgia, 30342, United States
St. Joseph's Hospital
Atlanta, Georgia, 30342, United States
Northside Hospital (CardioVascular Group Lawrenceville)
Lawrenceville, Georgia, 30045, United States
Northwestern Memorial Hospital
Chicago, Illinois, 60611, United States
Central DuPage Hospital
Winfield, Illinois, 60190, United States
Lutheran Hospital of Indiana
Fort Wayne, Indiana, 46801, United States
St. Vincent Hospital
Indianapolis, Indiana, 46240, United States
Kansas University Medical Center
Kansas City, Kansas, 66160, United States
Kansas City Cardiac Arrhythmia Research Foundation
Overland Park, Kansas, 66211, United States
Overland Park Mid America Cardiology
Overland Park, Kansas, 66211, United States
Via Christi Regional Medical Center - St. Francis Campus
Wichita, Kansas, 67214, United States
Baptist Health Lexington
Lexington, Kentucky, 40503, United States
Our Lady of the Lake Physician Group
Baton Rouge, Louisiana, 70808, United States
Cardiovascular Institute of the South
Houma, Louisiana, 70361, United States
MedStar Union Memorial Hospital
Baltimore, Maryland, 21218, United States
Tufts Medical Center
Boston, Massachusetts, 02111, United States
Beth Israel Deaconess Medical Center
Boston, Massachusetts, 02215, United States
Spectrum Health Butterworth Hospital
Grand Rapids, Michigan, 49503, United States
VA Medical Center Minneapolis
Minneapolis, Minnesota, 55417, United States
St. Cloud Hospital - Central MN Heart Clinic
Saint Cloud, Minnesota, 56303, United States
Jackson Heart Clinic
Jackson, Mississippi, 39216, United States
Bryan Heart
Lincoln, Nebraska, 68506, United States
CHI Health Creighton University Medical Center-Bergan Mercy
Omaha, Nebraska, 68124, United States
Cooper University Hospital
Camden, New Jersey, 08103, United States
New Mexico Heart Institute
Albuquerque, New Mexico, 87102, United States
South Shore University Hospital-Northwell
Bay Shore, New York, 11706, United States
Buffalo General Hospital
Buffalo, New York, 14203, United States
Mount Sinai Hospital
New York, New York, 10019, United States
New York Presbyterian Hospital/Cornell University
New York, New York, 10021, United States
Staten Island University Hospital Northwell
Staten Island, New York, 10305, United States
Mission Health & Hospitals
Asheville, North Carolina, 28801, United States
NC Heart & Vascular Research
Raleigh, North Carolina, 27607, United States
TriHealth Bethesda North Hospital
Cincinnati, Ohio, 45242, United States
The Cleveland Clinic Foundation
Cleveland, Ohio, 44195, United States
Hightower Clinical
Oklahoma City, Oklahoma, 73102, United States
Oklahoma Heart Institute at Utica
Tulsa, Oklahoma, 74104, United States
Pinnacle Health System
Harrisburg, Pennsylvania, 17105, United States
University of Pittsburgh Medical Center
Pittsburgh, Pennsylvania, 15213, United States
WellSpan Health
York, Pennsylvania, 17403, United States
Roper Hospital
Charleston, South Carolina, 29401, United States
Sanford USD Medical Center
Sioux Falls, South Dakota, 57117, United States
Erlanger Medical Center
Chattanooga, Tennessee, 37403, United States
Tennova Healthcare-Turkey Creek Medical Center
Knoxville, Tennessee, 37920, United States
Vanderbilt Heart & Vascular Institute
Nashville, Tennessee, 37232, United States
Texas Cardiac Arrhythmia
Austin, Texas, 78705, United States
Baylor All Saints Medical Center at Fort Worth
Forth Worth, Texas, 76104, United States
Park Plaza Hospital
Houston, Texas, 77004, United States
CHI St. Luke's Health Baylor College of Medicine Med. Ctr.
Houston, Texas, 77030, United States
Memorial Hermann Hospital
Houston, Texas, 77030, United States
The Methodist Hospital
Houston, Texas, 77030, United States
Memorial Katy Cardiology Associates
Houston, Texas, 77094, United States
The Heart Hospital Baylor Plano
Plano, Texas, 75093, United States
Methodist Texsan Hospital
San Antonio, Texas, 78201, United States
Heart Rhythm Associates
Shenandoah, Texas, 77380, United States
Sentara Norfolk General Hospital
Norfolk, Virginia, 23507, United States
Monongalia General Hospital
Morgantown, West Virginia, 26505, United States
Medical College of Wisconsin
Milwaukee, Wisconsin, 53226, United States
Royal Adelaide Hospital
Adelaide, South Australia, 5000, Australia
Fiona Stanley Hospital
Murdoch, Western Australia, 6150, Australia
Ottawa Heart Institute
Ottawa, Ontario, K1Y 4W7, Canada
Institut de Cardiologie de Montreal (Montreal Heart Inst.)
Montreal, H1T 1C8, Canada
CHUM
Montreal, H2X 3E4, Canada
Vancouver General Hospital (U of BC)
Vancouver, V5Z 1M9, Canada
Fakultni nemocnice Kralovske Vinohrady
Prague, 100 34, Czechia
Nemocnice Na Homolce
Prague, 150 30, Czechia
Skejby University Hospital
Aarhus, 8200, Denmark
Rigshospitalet
Copenhagen, 2100, Denmark
CHU Gabriel Montpied
Clermont-Ferrand, 63003, France
Institute Cardio. Paris-Sud - Institut Jacques Cartier
Massy, 91300, France
Mutualiste Montsouris
Paris, 75014, France
Hopital Haut Leveque
Pessac, 33604, France
Universitätsmedizin Berlin - Campus Benjamin Franklin (CBF)
Berlin, Brandenburg, 12203, Germany
Universitätsklinikum Schleswig-Holstein - Campus Lübeck
Lübeck, Schleswig-Holstein, 23562, Germany
Segeberger Kliniken GmbH
Bad Segeberg, 23795, Germany
St. Marien-Hospital-Bonn
Bonn, 53115, Germany
Cardioangiologisches Centrum am Bethanien Krankenhaus
Frankfurt, 60389, Germany
Klinikum der Justus-Liebig-Universität
Giessen, 35392, Germany
Universitätsmedizin der Johannes Gutenberg-Universität Mainz
Mainz, 55131, Germany
Internistisches Klinikum München SUD
Munich, 81379, Germany
Helios Klinikum Siegburg
Siegburg, 53721, Germany
Prince of Wales Hospital
Hong Kong, 999077, Hong Kong
Queen Elizabeth Hospital
Hong Kong, Hong Kong
The University of Hong Kong (Queen Mary Hospital)
Hong Kong, Hong Kong
Fondazione Toscana Gabriele Monasterio
Massa, 54100, Italy
Ospedale San Raffaele
Milan, 20132, Italy
Toyohashi Heart Center
Toyohashi, Aichi-ken, 441-8530, Japan
Chiba University
Chiba, Chiba, 260-8677, Japan
Kokura Memorial Hospital
Kitakyushu, Fukuoka, 802-8555, Japan
University of Tsukuba Hospital
Tsukuba, Ibaraki, 305-8576, Japan
Shonan Kamakura General Hospital
Kamakura, Kanagawa, 247-8533, Japan
Sendai Kousei Hospital
Sendai, Miyagi, 980-0973, Japan
Kurashiki Central Hospital
Kurashiki-shi, Okayama-ken, Japan
Toho University Ohashi Medical Center
Meguro-ku, Tokyo, 153-8515, Japan
Institute of Science Tokyo Hospital
Tokyo, Tokyo, 113-8519, Japan
Vilnius University Hospital Santariskiu Klinikos
Vilnius, 08661, Lithuania
St. Antonius Ziekenhuis
Nieuwegein, 3435 CM, Netherlands
Centralny Szpital Kliniczny Uniwersytetu Medycznego w Lodzi
Lodz, 92-213, Poland
Slaskie Centrum Chorob Serca
Zabrze, 41-800, Poland
Hospital Clinico San Carlos
Madrid, Madrid, Spain
Hospital de la Santa Creu I Sant Pau
Barcelona, 08025, Spain
Hospital Clinic I Provincial de Barcelona
Barcelona, 08036, Spain
Hospital Universitario de Salamanca
Salamanca, 37007, Spain
Center Inselspital Bern
Bern, 3010, Switzerland
Stadtspital Triemli
Zurich, 8063, Switzerland
The Royal Sussex County Hospital
Brighton, BN25BE, United Kingdom
Related Publications (1)
Reddy VY, Hylek E, Camm AJ, Halperin JL, Diener HC, Thaler D, Schmidt B, Hara H, Huisman MV, Price MJ, Lakkireddy D, Gage R, Zhao H, Jensen TP, Quintana M, Windecker S. Left Atrial Appendage Occlusion Versus NOACs in patients With Atrial Fibrillation: Rationale and Design of the CATALYST Trial. Am Heart J. 2026 Feb 2;296:107367. doi: 10.1016/j.ahj.2026.107367. Online ahead of print.
PMID: 41638386DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Vivek Reddy, MD
Mt. Sinai Medical Center
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 9, 2020
First Posted
January 13, 2020
Study Start
July 7, 2020
Primary Completion (Estimated)
January 1, 2029
Study Completion (Estimated)
April 1, 2031
Last Updated
February 10, 2026
Record last verified: 2026-02
Data Sharing
- IPD Sharing
- Will not share